Annual Operating Expenses
$75.64 M
+$6.97 M+10.15%
31 December 2023
Summary:
Inozyme Pharma annual total operating expenses is currently $75.64 million, with the most recent change of +$6.97 million (+10.15%) on 31 December 2023. During the last 3 years, it has risen by +$18.60 million (+32.62%). INZY annual operating expenses is now at all-time high.INZY Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$24.85 M
-$2.81 M-10.17%
30 September 2024
Summary:
Inozyme Pharma quarterly total operating expenses is currently $24.85 million, with the most recent change of -$2.81 million (-10.17%) on 30 September 2024. Over the past year, it has increased by +$6.78 million (+37.50%). INZY quarterly operating expenses is now -12.24% below its all-time high of $28.32 million, reached on 30 September 2020.INZY Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | +37.5% |
| 3 y3 years | +32.6% | +74.3% |
| 5 y5 years | +552.5% | +475.3% |
INZY Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +33.5% | -10.2% | +74.3% |
| 5 y | 5 years | at high | +552.5% | -12.2% | +475.3% |
| alltime | all time | at high | +552.5% | -12.2% | +475.3% |
Inozyme Pharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.85 M(-10.2%) |
| June 2024 | - | $27.66 M(+13.6%) |
| Mar 2024 | - | $24.34 M(+6.7%) |
| Dec 2023 | $75.64 M(+10.1%) | $22.81 M(+26.2%) |
| Sept 2023 | - | $18.07 M(+10.2%) |
| June 2023 | - | $16.39 M(-10.8%) |
| Mar 2023 | - | $18.37 M(-6.0%) |
| Dec 2022 | $68.67 M(+21.2%) | $19.53 M(+15.5%) |
| Sept 2022 | - | $16.91 M(+9.9%) |
| June 2022 | - | $15.39 M(-8.6%) |
| Mar 2022 | - | $16.84 M(-10.2%) |
| Dec 2021 | $56.65 M | $18.76 M(+31.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $14.26 M(+12.7%) |
| June 2021 | - | $12.65 M(+15.3%) |
| Mar 2021 | - | $10.97 M(-2.7%) |
| Dec 2020 | $57.04 M(+174.2%) | $11.27 M(-60.2%) |
| Sept 2020 | - | $28.32 M(+196.6%) |
| June 2020 | - | $9.55 M(+20.8%) |
| Mar 2020 | - | $7.91 M(+16.8%) |
| Dec 2019 | $20.81 M(+79.5%) | $6.77 M(+56.7%) |
| Sept 2019 | - | $4.32 M(-5.1%) |
| June 2019 | - | $4.55 M(-11.8%) |
| Mar 2019 | - | $5.16 M |
| Dec 2018 | $11.59 M | - |
FAQ
- What is Inozyme Pharma annual total operating expenses?
- What is the all time high annual operating expenses for Inozyme Pharma?
- What is Inozyme Pharma annual operating expenses year-on-year change?
- What is Inozyme Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Inozyme Pharma?
- What is Inozyme Pharma quarterly operating expenses year-on-year change?
What is Inozyme Pharma annual total operating expenses?
The current annual operating expenses of INZY is $75.64 M
What is the all time high annual operating expenses for Inozyme Pharma?
Inozyme Pharma all-time high annual total operating expenses is $75.64 M
What is Inozyme Pharma annual operating expenses year-on-year change?
Over the past year, INZY annual total operating expenses has changed by +$6.97 M (+10.15%)
What is Inozyme Pharma quarterly total operating expenses?
The current quarterly operating expenses of INZY is $24.85 M
What is the all time high quarterly operating expenses for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total operating expenses is $28.32 M
What is Inozyme Pharma quarterly operating expenses year-on-year change?
Over the past year, INZY quarterly total operating expenses has changed by +$6.78 M (+37.50%)